injection molding process

11
An Injection Molding Process for Manufacturing Highly Porous and Interconnected Biodegradable Polymer Matrices for Use as Tissue Engineering Scaffolds Adam Kramschuster, Lih-Sheng Turng Polymer Engineering Center, Department of Mechanical Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706-1572 Received 21 April 2008; revised 1 May 2009; accepted 15 July 2009 Published online 2 December 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.b.31523 Abstract: In this research, injection molding was combined with a novel material combination, supercritical fluid processing, and particulate leaching techniques to produce highly porous and interconnected structures that have the potential to act as scaffolds for tissue engineering applications. The foamed structures, molded with polylactide (PLA) and polyvinyl alcohol (PVOH) with salt as the particulate, were processed without the aid of organic solvents, which can be detrimental to tissue growth. The pore size in the scaffolds is controlled by salt particulates and interconnectivity is achieved by the co-continuous blending morphology of biodegradable PLA matrix with water-soluble PVOH. Carbon dioxide (CO 2 ) at the supercritical state is used to serve as a plasticizer, thereby imparting moldability of blends even with an ultra high salt particulate content, and allows the use of low processing temperatures, which are desirable for temperature-sensitive biodegradable polymers. Interconnected pores of 200 lm in diameter and porosities of 75% are reported and discussed. ' 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 366–376, 2010 Keywords: microcellular injection molding; tissue engineering; scaffolds; porous; manu- facturing INTRODUCTION Tissue engineering is an interdisciplinary field aimed at the development of biological substitutes that restore, maintain, or improve tissue function. 1 A highly porous biodegradable scaffold is essential to accommodate mammalian cells and guide their growth in three dimensions. 2 In the past, natural and synthetic polymers have routinely been used as sub- strates to provide this temporary scaffolding for transplanted cells as they excrete their extracellular matrix (ECM) and form new tissues or organs. 1–4 Synthetic polymers offer sev- eral advantages over natural polymers such as collagen and fibrin. They can be prepared in a reproducible manner in almost unlimited quantities, and their physical, chemical, and mechanical properties may be easily altered by chemical modifications. In addition, they can be easily processed with conventional polymer processing equipment. 5 Some com- mon synthetic biodegradable polymers currently used as scaffolding materials include polylactide (PLA) and polygly- colide (PGA), as well as their copolymers, and polycaprolac- tone (PCL). 2–4 Myriads of new materials—including tyrosine-derived polycarbonates and trimethylene carbonate- based materials—are also being explored as alternative syn- thetic polymers for tissue engineering scaffolds. 5–6 The function of tissue engineering scaffolds is to direct the growth of cells migrating from surrounding tissue (in the case of scaffold-guided regeneration) or seeded within the porous structure of the scaffold. 3 The scaffold must provide temporary support for cell adhesion, proliferation and differentiation, nutrient transport, and the excretion of waste while the cells secrete their own extracellular matrix (ECM). Ideally, a scaffold should have the following char- acteristics: (1) a three-dimensional and highly porous struc- ture with an interconnected pore network for cell growth and flow transport of nutrients and metabolic waste; (2) be biocompatible and bioresorbable with a controllable degra- dation and resorption rate to match cell/tissue growth in vitro and/or in vivo; (3) have suitable surface chemistry for cell attachment, proliferation, and differentiation; and (4) have mechanical properties to match those of the tissues at the site of implantation. 7 Porosity, Pore Size, and Interconnectivity Highly porous scaffolds are required to allow for cells to infiltrate and attach to the scaffold, to provide a high sur- Correspondence to: L.-S. Turng (e-mail: [email protected]) Contract grant sponsor: NSF; Contract grant number: DMI-0544729 ' 2009 Wiley Periodicals, Inc. 366

Upload: cansu

Post on 01-Oct-2015

215 views

Category:

Documents


2 download

DESCRIPTION

.

TRANSCRIPT

  • An Injection Molding Process for Manufacturing Highly Porousand Interconnected Biodegradable Polymer Matrices for Useas Tissue Engineering Scaffolds

    Adam Kramschuster, Lih-Sheng Turng

    Polymer Engineering Center, Department of Mechanical Engineering, University of Wisconsin-Madison, Madison,Wisconsin 53706-1572

    Received 21 April 2008; revised 1 May 2009; accepted 15 July 2009Published online 2 December 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.b.31523

    Abstract: In this research, injection molding was combined with a novel materialcombination, supercritical fluid processing, and particulate leaching techniques to producehighly porous and interconnected structures that have the potential to act as scaffolds fortissue engineering applications. The foamed structures, molded with polylactide (PLA) andpolyvinyl alcohol (PVOH) with salt as the particulate, were processed without the aid oforganic solvents, which can be detrimental to tissue growth. The pore size in the scaffolds iscontrolled by salt particulates and interconnectivity is achieved by the co-continuous blendingmorphology of biodegradable PLA matrix with water-soluble PVOH. Carbon dioxide (CO2) atthe supercritical state is used to serve as a plasticizer, thereby imparting moldability of blendseven with an ultra high salt particulate content, and allows the use of low processingtemperatures, which are desirable for temperature-sensitive biodegradable polymers.Interconnected pores of 200 lm in diameter and porosities of 75% are reported anddiscussed. ' 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 366376, 2010

    Keywords: microcellular injection molding; tissue engineering; scaffolds; porous; manu-facturing

    INTRODUCTION

    Tissue engineering is an interdisciplinary eld aimed at the

    development of biological substitutes that restore, maintain,

    or improve tissue function.1 A highly porous biodegradable

    scaffold is essential to accommodate mammalian cells and

    guide their growth in three dimensions.2 In the past, natural

    and synthetic polymers have routinely been used as sub-

    strates to provide this temporary scaffolding for transplanted

    cells as they excrete their extracellular matrix (ECM) and

    form new tissues or organs.14 Synthetic polymers offer sev-

    eral advantages over natural polymers such as collagen and

    brin. They can be prepared in a reproducible manner in

    almost unlimited quantities, and their physical, chemical,

    and mechanical properties may be easily altered by chemical

    modications. In addition, they can be easily processed with

    conventional polymer processing equipment.5 Some com-

    mon synthetic biodegradable polymers currently used as

    scaffolding materials include polylactide (PLA) and polygly-

    colide (PGA), as well as their copolymers, and polycaprolac-

    tone (PCL).24 Myriads of new materialsincluding

    tyrosine-derived polycarbonates and trimethylene carbonate-

    based materialsare also being explored as alternative syn-

    thetic polymers for tissue engineering scaffolds.56

    The function of tissue engineering scaffolds is to direct

    the growth of cells migrating from surrounding tissue (in

    the case of scaffold-guided regeneration) or seeded within

    the porous structure of the scaffold.3 The scaffold must

    provide temporary support for cell adhesion, proliferation

    and differentiation, nutrient transport, and the excretion of

    waste while the cells secrete their own extracellular matrix

    (ECM). Ideally, a scaffold should have the following char-

    acteristics: (1) a three-dimensional and highly porous struc-

    ture with an interconnected pore network for cell growth

    and ow transport of nutrients and metabolic waste; (2) be

    biocompatible and bioresorbable with a controllable degra-

    dation and resorption rate to match cell/tissue growth invitro and/or in vivo; (3) have suitable surface chemistry forcell attachment, proliferation, and differentiation; and (4)

    have mechanical properties to match those of the tissues at

    the site of implantation.7

    Porosity, Pore Size, and Interconnectivity

    Highly porous scaffolds are required to allow for cells to

    inltrate and attach to the scaffold, to provide a high sur-

    Correspondence to: L.-S. Turng (e-mail: [email protected])Contract grant sponsor: NSF; Contract grant number: DMI-0544729

    ' 2009 Wiley Periodicals, Inc.

    366

  • face area-to-volume ratio for polymer-cell interactions, and

    to obtain minimal diffusion constraints during cell culture.

    Past research has stated that a scaffold porosity of greater

    than 90% is important for tissue engineering applications.8

    However, much of the basis for this is due to early meth-

    ods (namely solvent casting/particulate leaching) being

    unable to achieve high interconnectivity at porosities less

    than 90%. In fact, researchers have used scaffolds with

    porosities ranging from 55 to 74% for bone growth due to

    better and more controllable mechanical properties at lower

    porosities.911

    The optimal pore size for tissue regeneration is depend-

    ent on the type of tissue.2 However, even for bone regener-

    ation, no consensus regarding the optimal pore size in

    scaffolds has been determined. Pore sizes ranging from 50

    to 710 lm have been suggested for bone regeneration, withmany studies stating that macropores in the range of 150 to

    350 lm are ideal.2,12,13 Therefore, macropores on the orderof hundreds of microns with an interconnecting network on

    the order of tens of microns has been deemed suitable for

    tissue regeneration. At the same time, the effects of surface

    chemistry, culture conditions, mechanical properties, and

    degradation rate play a large role in tissue formation, and

    will be discussed further.

    Biocompatibility and Degradation

    The material used for the polymeric scaffold must exhibit

    good biocompatibility, meaning that it must not elicit an

    unresolved inammatory response nor demonstrate extreme

    immunogenicity or cytotoxicity.14 For example, PLA

    hydrolyzes to lactic acid, which is a normal byproduct of

    muscle contractions in animals. The lactic acid is then fur-

    ther metabolized through the tricarboxylic acid cycle and

    excreted as carbon dioxide and water.15 The issue of bio-

    compatibility is directly linked to the degradation of the

    material as well. For instance, if the degradation rate of the

    polymer is too fast, not only will it cease to provide the

    necessary mechanical support for the tissue, the surround-

    ing tissue cannot eliminate the acid byproducts, resulting in

    an inammatory or toxic response.5,15 As discussed in Ref.

    16, some synthetic biodegradable polymers can be tailored

    to elicit specic degradation rates based on their composi-

    tion (e.g., PLGA).

    Surface Chemistry

    The nature of the polymer surface can affect the ability of

    cells and proteins to attach to its surface, proliferate, and

    differentiate. Polymers like PLA and PGA are relatively

    hydrophobic, and it is difcult to efciently and evenly

    seed cells into porous matrices fabricated from these poly-

    mers.17,18 The use of hydrophilic polyvinyl alcohol

    (PVOH)19 and many other methods of surface modication

    can be found in Refs. 2023 and the references cited

    therein.

    Mechanical Properties

    The mechanical properties of the scaffold fabricated should

    closely match the mechanical properties of the neotissues

    to be generated in order to provide support during the ini-

    tial stages of tissue growth. If the mechanical properties are

    too low, the scaffold could be deformed or crushed, leading

    to deformed tissue growth, or no tissue growth at all. At

    the same time, if the mechanical properties are too high,

    the cells may not be subjected to the proper in vivo condi-tions needed to support cell growth. Additionally, espe-

    cially in load-bearing instances, scaffold mechanical

    properties that exceed that of the surrounding bone may

    lead to stress-shielding, a condition where the surround-

    ing bone experiences a decrease in density. However, this

    is more prevalent with permanent implants. The mechanical

    properties of several tissues, including bone and cartilage,

    can be found in Table I.2,24

    Scaffold Processing

    Many methods for producing scaffolds using synthetic bio-

    degradable polymers have been developed and extensive

    reviews detailing these methods are available.25,12,13 How-

    ever, the majority of current scaffold fabrication techniques

    can be described as batch processes or use organic solvents,

    which can be detrimental to cell survival and tissue

    growth.13 While these techniques may be adequate and

    essential for studying the effects of the substrate material,

    porosity, pore size, interconnectivity of the pores, mechani-

    cal and chemical properties, growth factors, and nutrient

    transport on the effects of tissue regeneration both in vitroand in vivo, they do not address the need for cost-effectivemanufacturing processes to meet patient needs. The ability

    to mass produce highly porous, highly interconnected scaf-

    folds with complex geometries is essential to provide off-

    the-shelf availability.25

    Plastic injection molding has long been used to cost-

    effectively manufacture complex 3D parts. Mechanical pen-

    cils, automotive door panels, computer and cell phone

    housings, sunglasses, optical lenses, and many medical

    devices are all examples of injection-molded parts. The

    low-cost manufacturing, repeatability, and design exibility

    inherent in the injection molding process make it an ideal

    process to suit this wide variety of industries. These char-

    TABLE I. Mechanical Properties of Human Tissues

    Tensile

    Strength

    (MPa)

    Compressive

    Strength

    (MPa)

    Youngs

    Modulus

    (MPa)

    Cancellous bone 8 412 50100

    Cortical bone 60160 130180 330 3 103

    Cartilage 3.710.5 n/a 0.715.3

    Ligament 1346 n/a 65541

    Tendon 24112 n/a 1432310

    Adapted from Refs. 2 and 24.

    367INJECTION MOLDING PROCESS FOR MANUFACTURING HIGHLY POROUS POLYMER MATRICES

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • acteristics also make injection molding an ideal manufac-

    turing process to create 3D scaffolds, as long as high po-

    rosity (e.g., maximum porosities of 80% have been shown

    to be desirable for orthopedic applications12,26) and inter-

    connectivity can be imparted into the nished product.

    Recently, researchers have been striving to develop meth-

    ods by which these characteristics can be imparted into

    complex 2D and 3D structures via extrusion2729 and injec-

    tion molding,3034 respectively, which may have the poten-

    tial to act as tissue engineering scaffolds. However, the

    techniques that have been explored for 3D structures have

    either fallen short of scaffold requirements, such as poros-

    ity and interconnectivity,3033 or they involve the use of or-

    ganic solvents,34 which may be harmful to cells. This

    research aims to provide a novel method using microcellu-

    lar injection molding (to be discussed below) for the pro-

    duction of biodegradable scaffolds with high porosity and

    interconnectivity without the use of organic solvents.

    In this research, polylactide (PLA) was compounded

    with water-soluble polyvinyl alcohol (PVOH) and sodium

    chloride (NaCl) to create a composite blend. Utilizing

    microcellular injection molding and subsequent leaching of

    the samples in water resulted in PLA foams of over 75%

    porosity with high interconnectivity.

    MATERIALS AND EXPERIMENTS

    Materials

    Polylactide. Polylactide (PLA) was chosen as the biode-

    gradable polymer to serve as the matrix material for this

    research. Because of the extremely high cost of medical

    grade poly(D,L-lactide) (up to thousands of dollars per

    pound), nonmedical grade poly(D,L-lactide) (referred to

    simply as PLA throughout this article) was used for this

    research. The PLA used, NatureWorksTM PLA 3001D, is a

    lactic acid copolymer based on 1.5% D-lactic acid and

    98.5% L-lactic acid. It was purchased in pellet form from

    NatureWorks LLC. It has a specic gravity of 1.24 and a

    melt ow index around 15 g/10 min (1908C/2.16 kg). Itsglass transition temperature is 70 to 758C and its meltingtemperature is 1678C.

    Polyvinyl Alcohol. In order to create a co-continuous

    network to connect the pores in the PLA matrix, polyvinyl

    alcohol (PVOH) was chosen as the sacricial water-soluble

    polymer. In general, the water-soluble polymer selected

    must have a similar melt temperature and be immiscible

    with the chosen biodegradable polymer matrix. Previous

    theoretical and experimental studies have shown that PLA

    and PVOH form immiscible blends.35,36 Celvol 502 (Celan-

    ese Chemical Co.) supplied in granular form and AquaSol

    116 (A. Schulman) supplied in pellet form were donated

    for this research. Initial testing of co-continuity of the

    PLAPVOH blends was performed with Celvol 502. Celvol

    502 has a melting temperature of 1798C. Because AquaSol116 is supplied in pellet form and is designed for extrusion

    and injection molding applications, this material was used

    for subsequent compounding and injection molding experi-

    ments. AqualSol 116 has a specic gravity of 1.27, a melt-

    ing temperature of 1848C, and a melt ow index around10 g/10 min (2008C/5 kg).

    Sodium Chloride. Based on previous batch processes

    described in Refs. 3742, sodium chloride (NaCl) was used

    as the particulate. It can be easily size-reduced and sieved

    to the desired size range, it can be easily dissolved in

    water, and its melting point of 8018C ensures that it willnot melt at normal polymer processing conditions used for

    this research (under 2008C). The NaCl used for theseexperiments was reagent grade, purchased from Fisher Sci-

    entic with a specic gravity of 2.165.

    Carbon Dioxide. Carbon dioxide (CO2) was chosen as

    the benign blowing agent for the microcellular injection

    molding process. It has a much higher solubility than nitro-

    gen in most polymers and allows for larger cell sizes and a

    greater density reduction when used in the microcellular

    injection molding process.43

    Experiments

    Salt Reduction and Sieving. The NaCl particles were

    size reduced using a Wiley mill and a screen with 1 mm di-

    ameter holes. Once the particles were size reduced, they were

    sieved to a size range of 150 to 300 lm using sieve screensand a wet/dry sieve shaker (H-4328, Humboldt Mfg.).

    Compounding. The PLA, PVOH, and NaCl were com-

    pounded using a Davis Standard twin screw extruder with a

    screw diameter of 25 mm and an L/D ratio of 36.25. Thematerials were loaded into separate gravimetric feed hoppers

    to accurately meter the material at a constant feed rate of 40

    lb/h for all materials combined. The end cap temperature

    was set at 1858C and a screw rotation speed of 200 rpm wasused. Upon extrusion, the strands were cooled with com-

    pressed air and pelletized. The formulations compounded

    and analyzed in this article can be found in Table II.

    Microcellular Injection Molding. The injection molding

    experiments were performed on an Arburg Allrounder 320S

    with a 25 mm diameter screw and equipped with MuCell1

    Technology (Trexel, Inc.) (cf. Figure 1). Microcellular

    injection molding (or MuCell1) blends atmospheric gas

    (usually nitrogen or carbon dioxide) at a high-pressure

    supercritical state with the polymer melt to create a single-

    phase polymer-gas solution. To facilitate fast and homoge-

    neous mixing of the gas and polymer, and to maintain the

    single-phase solution prior to injection, the pressure inside

    the barrel is generally kept around 200 bar. During injec-

    tion, the sudden pressure drop triggers a thermodynamic

    instability of the polymer-gas solution. As a result, the gas

    starts emerging from the polymer-gas solution and forms

    368 KRAMSCHUSTER AND TURNG

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • numerous microscale cells. This process is similar to the

    batch foaming processes described in Refs. 44 and 45

    except that it is adapted to conventional injection molding

    equipment. It was used by Leicher et al.32 in an attempt to

    fabricate tissue engineering scaffolds with polyether-ure-

    thane. While this process can be used to impart porosity

    into the molded part, the supercritical uid also lls the in-

    terstitial sites between polymer molecules, effectively

    reducing the viscosity.4648 This enables the material to be

    processed at much lower pressures and temperatures.

    For these experiments, the pellets compounded in the

    twin screw extruder were dried overnight at 558C toremove any residual moisture. The materials were injection

    molded with a maximum barrel temperature of 1858C anda wt % SCF CO2 content of 2.2. The molded samples were

    impact bars with dimensions of 166 mm by 12.9 mm by

    4.8 mm. To study the repeatability of the results, at least

    10 samples were injection molded and subsequently

    leached under each material and process condition combi-

    nation, and at least three specimens were tested and ana-

    lyzed to ensure consistency of the results and to obtain the

    standard deviation.

    Leaching. After injection molding, the molded samples

    were leached in deionized water for up to 48 h using the

    setup depicted in Figure 2. The continuous supply of water

    was necessary to ush the PVOH as it absorbed water and

    swelled before dissolving. Select samples were removed

    every 3 to 6 h for testing. A water pump (Via Aqua

    1300A) continuously pumped water into the top of the res-

    ervoir. The water exited the bottom of the reservoir and

    cycled back through the pump. The water was changed ev-

    ery 6 h. Because of the lack of interconnectivity with the

    NaClPLA formulation, these samples were cryogenically

    fractured and then leached to observe the morphology. For

    the PLAPVOH blend and NaClPLAPVOH composite

    blend, the samples were leached and subsequently cryo-

    genically fractured for analysis.

    Scanning Electron Microscopy. The morphology of the

    injection-molded samples was evaluated using a JEOL

    JSM-6100 scanning electron microscope (SEM) with an

    accelerating voltage of 15 kV. The samples were leached

    and cryogenically fractured using liquid nitrogen and then

    sputtered with gold for 120 s.

    Thermogravimetric Analysis. The residual salt content

    of the NaClPLAPVOH composite blends was analyzed

    using a Perkin Elmer thermogravimetric analyzer (TGA).

    The samples were heated from 50 to 7008C at a rampspeed of 408C/min.

    Porosity Calculation. The porosity (or void fraction) of

    the leached samples was determined by weighing them and

    measuring the dimensions of the weighed samples to obtain

    the volume. Equation (1) was then applied to determine the

    porosity.

    Vf 1qappqPLA

    3100 1

    where Vf is the void fraction or porosity of the sample,qapp is the apparent density of the porous scaffold, andqPLA is the known density of the matrix material (PLA 51.24 g/cm3).

    RESULTS

    Morphology

    NaClPLA (4159 vol %). The samples were molded,

    leached with water, cryogenically fractured, and examined

    with SEM as described previously. Figures 3 and 4 clearly

    show a lack of interconnectivity in the NaClPLA sample.

    The outside edge of the sample is porous due to direct con-

    TABLE II. Formulations Compounded in the Twin ScrewExtruder

    Materials

    Composition

    (vol %)

    Blend 1 NaClPLA 41/59

    Blend 2 PLAPVOH 67/33

    Blend 3 NaClPLAPVOH 60/20/20

    Figure 2. Schematic of the setup used for leaching the injection-molded samples.

    Figure 1. Schematic of the microcellular injection molding processwith characteristic morphology.

    369INJECTION MOLDING PROCESS FOR MANUFACTURING HIGHLY POROUS POLYMER MATRICES

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • tact with the water during leaching and the center portion

    of the sample has closed pores due to CO2 foaming associ-

    ated with the microcellular injection molding (cf. Figure 3).

    The porous skin surrounding the (mostly) solid center is

    more clearly dened in Figure 4. Figure 5 shows a magni-

    ed view of a sample that was fractured and subsequently

    leached. Therefore, the entire cross-section is directly

    exposed to water, allowing for the entire surface to be dis-

    solved leaving behind the pores due to the NaCl particles.

    PLAPVOH (6733 vol %). Because of the lack of inter-

    connectivity in the NaClPLA composites, the use of a

    water-soluble polymer and PLA was proposed to connect

    the NaCl particulates in the PLA matrix. As discussed pre-

    viously, PLA and PVOH have been shown to be immisci-

    ble, though their ability to form a co-continuous blend

    needed to be determined for this research. PLA was com-

    pounded with Celvol 502 to form a 6733 vol % blend.

    This material was leached and subsequently fractured.

    Figure 6 shows a magnied SEM image of the cross sec-

    tion of an extruded strand. Porous channels ranging from 1

    to 30 lm were formed throughout the entire cross sectionof the part, with the majority of channel diameters less

    than 5 lm.In Figure 6, the edge of the cross section of the extruded

    strand is also highlighted. Porous channels can be seen on

    the outside of the strand that allowed for the entire leaching

    of the sample. From these SEM images, it was determined

    that PLA and PVOH form a co-continuous structure that

    could be potentially used to create connecting channels

    between NaCl particles to form a highly porous biodegrad-

    able scaffold.

    Figure 3. The porous outside and center are due to direct contactwith water and gas foaming, respectively.

    Figure 4. The porous outer edge and solid core are more clearlydened.

    Figure 5. Thin walls of PLA separate three pores left by directleaching of the NaCl particles.

    Figure 6. Channels on the outside surface allowed for the dissolu-tion of PVOH in the center of the part that did not come in directcontact with water when rst placed in the leaching reservoir.

    370 KRAMSCHUSTER AND TURNG

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • NaClPLAPVOH (602020 vol %). Combining polyvi-

    nyl alcohol and particulate leaching with microcellular

    injection molding resulted in a porous and fully intercon-

    nected sample, Figure 7. For the samples to be fully

    leached, the PVOH would have had to form a continuous

    phase throughout the PLA matrix to connect the NaCl par-

    ticles. Evidence of this occurring can be seen in Figure 8.

    Several magnied images of pores left behind by NaCl par-

    ticles are shown with smaller pores (less than 10 lm) thatwere left behind by the PVOH and possibly NaCl particles

    that were broken down during processing (cf. Figure 9).

    Figure 10 displays the effect of leaching time on the dis-

    solution of NaCl and PVOH. In Figure 10(a), the sample

    had not been leached (0 h). The voids in this part were due

    to a combination of microcellular CO2 gas foaming and a

    difference in thermal coefcients of expansion for NaCl

    compared to PLA and PVOH. Visual observation of Figure

    10 shows a disappearance of the solid core after 6 h, but it

    is difcult to quantitatively determine when all of the salt

    Figure 7. Cross-section of the NaClPLAPVOH (602020 vol %)composite blend showing what appears to be a fully leached sur-

    face with uniform porosity throughout the part.

    Figure 8. SEM showing the pores left behind by NaCl particles and the smaller channel diameters left behind by the PVOH that provided theinterconnected network for leaching.

    371INJECTION MOLDING PROCESS FOR MANUFACTURING HIGHLY POROUS POLYMER MATRICES

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • has been dissolved. This topic is quantitatively assessed in

    the subsequent section.

    NaCl Content

    Blend Composition. Because of the different densities

    of the NaCl, PLA, and PVOH, a set of equations was

    solved simultaneously to determine the weight percent of

    each material to obtain the desired composition. For a 60

    2020 composite blend of NaClPLAPVOH, 72.13% of

    the composite blend weight should be NaCl. Using TGA,

    the NaCl content of the 602020 composite blend was

    found to be 69.7 wt % (cf. Figure 11) or 57 vol %. Thisdeviation from the theoretical NaCl content can be attrib-

    uted to two causes: (1) NaCl crystals were lost when the

    extruded strands were pelletized due to the chopping action

    of the pelletizer, or (2) the gravimetric feeders were not

    100% accurate when metering the three materials into the

    extruder.

    Residual NaCl Content. TGA was used to quantitatively

    determine the residual NaCl content of the 602020

    NaClPLAPVOH composite blend as a function of leach-

    ing time (cf. Figure 12). After heating to 7008C, the onlyremaining component of the composite blend was the

    NaCl. After leaching for 18 h, the wt % NaCl was 3.8%and reached a plateau of 3.4% after 24 h. This translatesto a vol % of 2.0% for a solid composite blend. How-ever, the samples analyzed were highly porous as evi-

    denced by the SEM images shown previously. Therefore,

    the actual vol % of NaCl in the porous structure is much

    lower than 2.0% and is a function of wt % NaCl and po-

    rosity. A 75% porous sample with a residual NaCl content

    of 3.4 wt % has a vol % NaCl under 0.5%.

    Porosity. The porosity of the 602020 vol% NaCl

    PLAPVOH composite blend was calculated using Eq. (1).

    The porosities as a function of leaching time for the 60

    2020 NaClPLAPVOH composite blend are shown in

    Figure 13. For samples leached 18 h or more, the porosity

    reached 75%.

    DISCUSSION

    Morphology

    NaClPLA (4159 vol %). Previous research using the

    solvent casting/particulate leaching (SC/PL) technique dis-

    cussed in Refs. 3742 has shown that salt contents of less

    than 90 vol % resulted in poor interconnectivity. However,

    no published literature had previously examined the use of

    particulate leaching with microcellular injection molding.

    Therefore, this formulation served as a preliminary study

    for the evaluation of this technique. The lack of intercon-

    nectivity in the NaClPLA samples was due to the salt par-

    ticles becoming encapsulated in PLA during compounding

    and injection molding. Figure 5 clearly shows thin walls of

    PLA separating three pores left by NaCl particles. Had

    these samples not been fractured prior to leaching, the lack

    of interconnectivity in the sample would have prevented

    these pores from being formed.

    PLAPVOH (6733 vol %). Washburn et al.27,28 origi-

    nally proposed using a water-soluble polymer, polyethylene

    oxide (PEO), and a biodegradable polymer, PCL, to create

    co-continuous blends for tissue engineering scaffolds. A

    subsequent leaching step in water leaves a porous matrix

    that is fully interconnected. This technique and its improve-

    ments (including the incorporation of NaCl as a particulate)

    were highlighted by Reignier and Huneault.29

    No attempts at altering process conditions were made to

    modify the channel diameters of the extruded PLAPVOH

    blend. Previous research summarized by Sundararaj49

    reported that the nal domain size is about one 1 lm forthe majority of uncompatibilized polymer blends, regard-

    less of processing conditions. Part of the reason for this is

    Figure 9. SEM of the sieved NaCl particles (a) before compounding,and (b) after compounding.

    372 KRAMSCHUSTER AND TURNG

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • Figure 10. Morphology as a result of varying leaching time: (a) 0 h, or not leached at all, (b) 3 h, (c) 6 h, and (d) 30 h.

    Figure 11. TGA curve showing the wt % of the 602020 vol %NaClPLAPVOH composite blend as a function of temperature. At

    the higher temperatures, the NaCl is the only remaining componentof the composite blend.

    Figure 12. Graph showing the wt % NaCl remaining from the 602020 vol % NaClPLAPVOH composite blend after the TGAexperiments for different leaching times.

    373INJECTION MOLDING PROCESS FOR MANUFACTURING HIGHLY POROUS POLYMER MATRICES

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • that the dispersed phase (PVOH in this case) size scale

    changes from millimeters to microns within a very short

    period. In this case, the use of a granular PVOH (Celvol

    502) means the initial size scale of the dispersed phase was

    already on the order of hundreds of microns or smaller. It

    can be assumed that during twin screw extrusion, the gran-

    ular PVOH was intensively mixed, further size-reducing

    the granules into the micron-sized channel diameters

    observed in Figure 6. However, for cell and nutrient trans-

    port to occur and for excretion of waste, it is necessary for

    the pores and interconnecting channels to be at least the

    size of a cell in suspension, or 10 lm.50 While the highsurface area-to-volume ratio that results from small pores

    and interconnecting channels may be preferred, median

    pore sizes on the order of 32 lm have led to more osteoidgrowth in scaffolds when compared to scaffolds with me-

    dian pore sizes on the order of 16 lm.9 Future work inorder to coarsen the phases of the scaffolds prepared in this

    study through annealing51 may be necessary in order to

    allow for sufcient cell and nutrient transport as well as

    the excretion of waste.

    NaClPLAPVOH (602020 vol %). Based on the results

    of the NaClPLA composite and the PLAPVOH blend, a

    NaClPLAPVOH composite blend was compounded using

    the twin screw extruder and injection molded. Batch proc-

    esses utilizing polymer extraction,2729,52 a combination of

    gas foaming and particulate leaching,5357 and the aforemen-

    tioned scaffold manufacturing processes provided the base-

    line for this material composition and process. A different

    PVOH (AquaSol 116) was used for these experiments than

    what was used for the 67-33 PLAPVOH blend (Celvol

    502). AquaSol 116 is supplied in pellet form designed for

    extrusion and injection molding, and it possesses a slightly

    higher melting temperature than Celvol 502. SEM images of

    the 602020 vol % NaClPLAPVOH composite blend

    show what appears to be a fully leached part with pores

    formed by leaching the salt particles and the PVOH (cf.

    Figure 7).

    NaCl Content

    Porosity. Equation (1) assumes that PLA, with a density

    of 1.24 g/cm3, is the only remaining material in the porous

    structure. However, this is not the case as evidenced in Fig-

    ure 12 using TGA. For example, due to the extremely high

    wt % NaCl in the 602020 samples that had not been

    leached, using Eq. (1) results in a porosity of 234.89%.This is clearly not the case. Therefore, qapp in Eq. (1) wasre-calculated to calculate the actual porosities of the

    foamed structures.

    From Figure 13, it is clear that a maximum porosity of

    75% was achieved after leaching the samples for 18 h.This trend corresponds well with the residual NaCl content

    shown in Figure 12. However, according to the original

    composition of the 602020 NaClPLAPVOH composite

    blend, the porosity should be at least 80% considering that

    the NaCl and PVOH should both be fully extracted. How-

    ever, the presence of residual NaCl, the apparent loss of

    NaCl during pelletizing, and the likelihood that the gravi-

    metric feeders were not 100% accurate when compounding

    the material, lends insight into this discrepancy. If the

    NaCl and PVOH contents had been 60% and 20% by vol-

    ume, respectively, and had been fully extracted, the poros-

    ity of the samples would have been greater than 80% due

    to the water-soluble materials and the presence of CO2foaming. Further exploration into using a lower viscosity

    PVOH may lead to higher interconnectivity, resulting in

    less residual NaCl content and higher porosity.

    CONCLUSION

    This work represents the rst time that injection molding

    has been used to create highly porous interconnected poly-

    mer matrices without the use of organic solvents. Porosities

    of more than 75% with high interconnectivity were

    achieved. Further work to control and quantitatively mea-

    sure the morphology, reduce the residual NaCl content, use

    medical grade materials suitable for a cell line experiment,

    and evaluate the mechanical properties of these structures

    will provide more insight into the feasibility of using injec-

    tion molding to mass produce biodegradable tissue engi-

    neering scaffolds.

    The authors would like to acknowledge the USDA ForestProducts Laboratory for use of their twin screw extruder andTGA, Celanese Chemical Co. and A. Schulman for donating thepolyvinyl alcohol, Trexel, Inc. for the donation of a special injec-tion molding screw, and Alex Chandra and Brian Ralston forassisting in the experiments.

    Figure 13. Graph showing the percent porosity of the molded sam-ples as a function of leaching time. The porosity reaches a plateau

    of 75% after 18 h. The error bars represent 6 one standarddeviation.

    374 KRAMSCHUSTER AND TURNG

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • REFERENCES

    1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920926.

    2. Yang S, Leong K, Du Z, Chua C. The design of scaffolds foruse in tissue engineering. I. Traditional factors. Tissue Eng2001;7:679689.

    3. Thomson RC, Shung AK, Yaszemski MJ, Mikos AG. Poly-mer scaffold processing. In: Lanza RP, Langer R, Vacanti JP,editors. Principles of Tissue Engineering. San Diego: Aca-demic Press; 2000. pp 251262.

    4. Cheung H, Lau K, Lu T, Hui D. A critical review on poly-mer-based bio-engineered materials for scaffold development.Composites B 2007;38:291300.

    5. Hutmacher DW. Polymers for medical applications. In:Buschow KHJ, Cahn RW, Flemings MC, Ilschner B, KramerEJ, Mahajan S, editors. Encyclopedia of Materials: Science andTechnology. Oxford: Elsevier Science; 2001. pp 76647673.

    6. Martina M, Hutmacher DW. Biodegradable polymers applied intissue engineering research: A review. Polym Int 2007;56:145157.

    7. Hutmacher DW. Scaffolds in tissue engineering bone and car-tilage. Biomaterials 2000;21:25292543.

    8. Freed LE, Vunjaknovakovic G, Biron RJ, Eagles DB, LesnoyDC, Barlow SK, Langer R. Biodegradable polymer scaffoldsfor tissue engineering. Biotechnology 1994;12:689693.

    9. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, ThomasCH, Nuber GW, Glorieux FH, Travers R, Sprague SM. Engi-neering bone regeneration with bioabsorbable scaffolds withnovel microarchitecture. Tissue Eng 1999;5:3551.

    10. Sherwood JK, Riley SL, Palazzolo R, Brown SC, MonkhouseDC, Coates M, Grifth LG, Landeen LK, Ratcliffe A. Athree-dimensional osteochondral composite scaffold for articu-late cartilage repair. Biomaterials 2002;23:47394751.

    11. Shao XX, Hutmacher DW, Ho ST, Goh J, Lee EH. Evalua-tion of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials 2006;27:10711080.

    12. Karande TS, Ong JL, Agrawal CM. Diffusion in musculoskel-etal tissue engineering scaffolds: Design issues related to po-rosity, permeability, architecture, and nutrient mixing. AnnBiomed Eng 2004;32:17281743.

    13. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds formuskuloskeletal tissue engineering. J Biomed Mater 2001;55:141150.

    14. Mikos AG, Temenoff JS. Formation of highly porous biode-gradable scaffolds for tissue engineering. Electron J Biotech2000;3:114119.

    15. Middleton JC, Tipton AJ. Synthetic biodegradable polymersas orthopedic devices. Biomaterials 2000;21:23352346.

    16. Miller RA, Brady JM, Cutright DE. Degradation rates of oralresorbable implants (polylactates and polyglycolates): Ratemodication with changes in PLA/PGA copolymer ratios.J Biomed Mater Res 1977;11:711719.

    17. Mooney DJ. Tissue engineering with biodegradable polymermatrices. Southern Biomedical Engineering Conference Pro-ceedings, Dayton, OH, 1996. pp 537540.

    18. Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role ofmaterial surfaces in regulating bone and cartilage cellresponse. Biomaterials 1996;17:137146.

    19. Oh SH, Kang SG, Kim ES, Cho SH, Lee JH. Fabrication andcharacterization of hydrophilic poly(lactic-co-glycolic acid)/poly(vinyl alcohol) blend cell scaffolds by melt-molding par-ticulate leaching method. Biomaterials 2003;24:40114021.

    20. Saltzman WM. Cell Interactions with polymers. In: Lanza RP,Langer R, Vacanti JP, editors. Principles of Tissue Engineer-ing. San Diego: Academic Press; 2000. pp 221235.

    21. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineer-ing. Ann Biomed Eng 2004;32:477486.

    22. Cao Y, Croll TI, Cooper-White JJ, OConnor AJ, StevensGW. Production and surface modication of polylactide-basedpolymeric scaffolds for soft tissue engineering. Methods MolBiol 2004;238:87112.

    23. Agrawal CM, Carter J, Ong JL. Basics of polymeric scaffoldsfor tissue engineering. J ASTM Int 2006;3:110.

    24. Baji A, Wong S-C, Srivatsan TS, Njus GO, Mathur G. Process-ing methodologies for polycaprolactone-hydroxyapatite com-posites: A review. Mater Manuf Process 2006;21:211218.

    25. Nerem RM. The challenge of imitating nature. In: Lanza RP,Langer R, Vacanti JP, editors. Principles of Tissue Engineer-ing. San Diego: Academic Press; 2000. pp 915.

    26. Golstein AS, Zhu GM, Morris GE, Meszlenyi RK, MikosAG. Effect of osteoblastic culture conditions on the structureof poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng1999;5:421433.

    27. Washburn NR, Simon CG Jr, Karim A, Amis EJ. Develop-ment of biodegradable polymer scaffolds using co-extrusion.Mater Res Soc Symp Proc 2001;662:LL1.6.1LL1.6.5.

    28. Washburn NR, Simon CG Jr, Tona A, Elgendy HM, KarimA, Amis EJ. Co-extrusion of biocompatible polymers for scaf-folds with co-continuous morphology. J Biomed Mater Res2002;60:2029.

    29. Reignier J, Huneault MA. Preparation of interconnectedpoly(e-caprolactone) porous scaffolds by a combination ofpolymer and salt particulate leaching. Polymer 2006;47:47034717.

    30. Gomes ME, Ribeiro AS, Malafaya PB, Reis RL, Cunha AM.A new approach based on injection moulding to produce bio-degradable starch-based polymeric scaffolds: Morphology,mechanical and degradation behaviour. Biomaterials 2001;22:883889.

    31. Neves NM, Kouyumdzhiev A, Reis RL. The morphology, me-chanical properties and ageing behavior of porous injectionmolded starch-based blends for tissue engineering scaffolding.Mater Sci Eng C 2005;25:195200.

    32. Leicher S, Will J, Haugen H, Wintermantel E. MuCell1 tech-nology for injection molding: A processing method for poly-ether-urethane scaffolds. J Mater Sci 2005;40:46134618.

    33. Haugen H, Will J, Fuchs W, Wintermantel E. A novel proc-essing method for injection-molded polyether-urethane scaf-folds, Part 1: Processing. J Biomed Mater Res Part B 2006;77:6572.

    34. Wu L, Jing D, Ding J. A room-temperature injection mold-ing/particulate leaching approach for fabrication of biodegrad-able three-dimensional porous scaffolds. Biomaterials 2006;27:185191.

    35. Jawalkar SS, Aminabhavi TM. Molecular modeling simula-tions and thermodynamic approaches to investigate compati-bility/incompatibility of poly(L-lactide) and poly(vinylalcohol) blends. Polymer 2006;47:80618071.

    36. Shuai X, He Y, Asakawa N, Inoue Y. Miscibility and phase struc-ture of binary blends of poly(L-lactide) and poly(vinyl alcohol). JAppl Polym Sci 2001;81:762772.

    37. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R.Preparation and characterization of poly(L-lactic acid) foams.Polymer 1994;35:10681077.

    38. Ma PX, Choi J-W. Biodegradable polymer scaffold with well-dened interconnected spherical pore network. Tissue Eng2001;7:2333.

    39. Mikos AG, Georgios S, Leite SM, Vacanti JP, Langer R.Laminated three-dimensional biodegradable foams for use intissue engineering. Biomaterials 1993;14:323330.

    40. Murphy WL, Dennis RG, Kileny JL, Mooney DJ. Salt fusion:An approach to improve pore interconnectivity within tissueengineering scaffolds. Tissue Eng 2002;8:4352.

    41. Widmer MS, Gupta PK, Lu L, Meszlenyi RK, Evans G,Brandt K, Savel T, Gurlek A, Patrick CW Jr, Mikos AG.

    375INJECTION MOLDING PROCESS FOR MANUFACTURING HIGHLY POROUS POLYMER MATRICES

    Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • Manufacture of porous biodegradable polymer conduits by anextrusion process for guided tissue regeneration. Biomaterials1998;19:19451955.

    42. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG,Langer R. Neocartilage formation in vitro and in vivo usingcells cultured on synthetic biodegradable polymers. J BiomedMater Res 1993;27:1123.

    43. Okamoto KT. Microcellular Processing. Cincinnati: HanserGardner; 2003.

    44. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R.Novel approach to fabricate porous sponges of poly(DL-lactic-co-glycolic acid) without the use of organic solvents. Bioma-terials 1996;17:14171422.

    45. Wang X, Wei L, Kumar V. Solvent free fabrication of biode-gradable porous polymers. ASME Manuf Eng Div 2004;15:595602.

    46. Kwag C, Manke CW, Gulari E. Rheology of molten polysty-rene with dissolved supercritical and near-critical gases.J Polym Sci Part B: Polym Phys 1999;37:27712781.

    47. Royer JR, Gay YJ, Desimone JM, Khan SA. High-pressurerheology of polystyrene melts plasticized with CO2: Experi-mental measurement and predictive scaling relationships.J Polym Sci Part B: Polym Phys 2000;38:31683180.

    48. Kwag C, Manke CW, Gulari E. Effects of dissolved gas onviscoelastic scaling and glass transition temperature of poly-styrene melts. Ind Eng Chem Res 2001;40:30483052.

    49. Sundararaj U. Phase morphology development in polymerblends: Processing and experimental aspects. In: Harrats C,Thomas S, Groeninck, G, editors. Micro- and Nanostructured

    Multiphase Polymer Blend Systems. Boca Raton: CRC Press;2006. pp 133164.

    50. Lu L, Mikos AG. Importance of new processing techniques intissue engineering. MRS Bull 1996;21:2832.

    51. Omonov TS, Harrats C, Groeninckx G, Moldenaers P. Anisot-ropy and instability of the co-continuous phase morphology inuncompatibilized and reactively compatibilized polypropyl-ene/polystyrene blends. Polymer 2007;48:52895302.

    52. Tsuji H, Smith R, Boneld W, Ikada Y. Porous biodegradablepolyesters. I. Preparation of porous poly(L-lactide) lms byextraction of poly(ethylene oxide) from their blends. J ApplPolym Sci 2000;75:629637.

    53. Harris LD, Kim B-S, Mooney DJ. Open pore biodegradablematrices formed with gas foaming. J Biomed Mater Res1998;42:396402.

    54. Riddle KW, Mooney DJ. Role of poly(lactide-co-glycolide)particle size on gas-foamed scaffolds. J Biomed Mater ResPolym Ed 2004;15:15611570.

    55. Sheridan MH, Shea LD, Peters MC, Mooney DJ. Bioabsorb-able polymer scaffolds for tissue engineering capable of sus-tained growth factor delivery. J Control Release 2000;64:91102.

    56. Nam YS, Yoon JJ, Park TG. A novel fabrication method ofmacroporous biodegradable polymer scaffolds using gas foam-ing salt as a porogen additive. J Biomed Mater Res Part B2000;53:17.

    57. Yoon JJ, Park TG. Degradation behaviors of biodegradablemacroporous scaffolds prepared by gas foaming of efferves-cent salts. J Biomed Mater Res 2001;55:401408.

    376 KRAMSCHUSTER AND TURNG

    Journal of Biomedical Materials Research Part B: Applied Biomaterials